Review Article
Valuing the Economic Costs of Allergic Rhinitis, Acute Bronchitis, and Asthma from Exposure to Indoor Dampness and Mold in the US
Table 5
Costs under optional calculation scenarios.
| | | Option 1 (million ) | Option 2 (million ) | Option 3 (million ) |
(Million ) |
| | AR (gov) | 2592.75 | NA | NA | — | | AR (alt) | 3194.74 | NA | NA | — | | Asthma hosp | 1,035.18 | 1,066.18 | 1,096.78 | — | | Acute bronch hosp | 343.06 | 365.71 | 363.01 | — |
| | Option 4 | (a) | (b) | (c) | (d) |
| | AR (gov) | 2,738.08 | 2,930.38 | 3,151.71 | 3992.17 | | AR (alt) | 3340.03 | 3532.33 | 3753.66 | 4756.64 | | Asthma | 1159.76 | 1248.20 | 1349.98 | 1709.97 | | Acute bronch | 476.45 | 483.26 | 507.62 | 575.30 |
|
|
